Childrens Tylenol Recall

    By Melly Alazraki

    | 11:00AM 12/16/2010
    The bad news doesn't end for Johnson & Johnson as FDA inspectors continue to find problems at the Pennsylvania plant that was the source of a massive recall of children's medicines earlier this year.

    By Melly Alazraki

    | 10:55AM 10/19/2010
    Tylenol and Band-Aid maker Johnson & Johnson announced on Tuesday that its sales declined 0.7% to $15 billion in the third quarter, compared to the same quarter last year, as domestic sales were "significantly impacted" by recent successive recalls. Domestic sales declined 2.5%.

    By Danny King

    | 4:16PM 9/30/2010
    In testimony before Congress Thursday, Johnson & Johnson's CEO apologized for the problems that have beset his company, including the quality issues with its children's medicines and the "phantom recall" of a batch of Motrin. He also said new batches of its children's medicines should start shipping next week.

    By Melly Alazraki

    | 11:45AM 9/21/2010
    Was Johnson & Johnson aware of problems with its Children's Tylenol months before the recall? The House Oversight Committee has invited an FDA commissioner and Johnson & Johnson chairman to a hearing next week to address this and other questions surrounding the massive recall of children's medicines earlier this year.

    By Melly Alazraki

    | 11:17AM 8/17/2010
    The latest quarterly filing from Warren Buffett's Bekshire Hathaway shows what changes the Oracle of Omaha made to his portfolio. What led him to buy into payment processor Fiserv and raise his stake in J&J?

    By Melly Alazraki

    | 8:15AM 7/20/2010
    Johnson & Johnson's earnings for the second quarter of 2010 rose 5.4% to $3.4 billion, or $1.23 per share, from $3.2 billion or $1.15 per share, the company announced Tuesday morning. Adjusted earnings, which exclude litigation costs, were $1.21 per share.

    By Melly Alazraki

    | 9:00AM 7/09/2010
    Johnson & Johnson subsidiary McNeil recalled another batch of over-the-counter medicines Thursday. The specific lots of Tylenol, Motrin and Benadryl products may have been contaminated with trace amounts of a chemical that gives them a musty or moldy odor.

    By Melly Alazraki

    | 9:53AM 6/11/2010
    Johnson & Johnson is being accused of stonewalling a congressional investigation into the recent recall of the company's children's medicines, The New York Times reported.

    By Jorgen Wouters

    | 7:20PM 5/25/2010
    The Food and Drug Administration is reportedly investigating reports of at least 775 serious side effects from drugs recalled by McNeil Consumer Healthcare, a division of Johnson & Johnson. Included in those reports were 30 deaths, nearly all of which were not linked to McNeil's recall of...

    By Mitch Lipka

    | 11:02AM 9/24/2009
    Parents: Check your medicine cabinets. Tylenol is quietly recalling batches of children and infant Tylenol liquid made between April 2008 and June 2008 after bacteria was found in one of the raw materials used to make the product. McNeil Consumer Healthcare, the subsidiary of Johnson & Johnson...